The company grew fourth-quarter earnings 12% year over year. Revenue grew 4.6% to $32.83 billion, Umar said.
General merchandise sales sank 2% on lower store traffic, but CVS saw a big boost in pharmaceutical sales, which were up 7% as subscription fills climbed 3.8%, Umar added.
Some investors have become worried about the company's future prospects after it announced that it would stop selling tobacco products by October of this year.
However, the company reaffirmed 2014 guidance, easing investors' worries for now. Shares were up nearly 3% Tuesday trading.-- Written by Bret Kenwell in Petoskey, Mich. Follow @BretKenwell
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts